The digital healthcare landscape in China is undergoing a significant transformation, driven by advancements in artificial intelligence (AI). Recently, prominent players in the sector, including Yidu Technology, Eagle Eye Technology, Wanda Information, and Zhiyun Health, have publicly announced their integration with DeepSeek, a cutting-edge AI modelThis development marks a pivotal moment in the evolution of AI in healthcare, signaling a concerted effort to harness technology to enhance various facets of medical services.
One of the most striking advancements comes from Eagle Eye Technology, which upgraded its proprietary Wan Yu Medical Model and successfully integrated it with the DeepSeek-R1 model on February 7. This model benefits from a decade's worth of accumulated knowledge in the medical vertical, featuring insights from over 30 million real-world clinical data records, 800 evidence-based medical knowledge graphs, and in-depth analyses of treatment paths utilized by top-tier hospital specialistsWith this upgrade, the Wan Yu Medical Model makes significant strides in three critical areas: it enhances both the efficiency and accuracy of clinical diagnoses, provides more professional report interpretations, and offers a personalized health management experience.
Similarly, Yidu Technology announced on February 6 that it had incorporated the DeepSeek AI model into its own "AI Medical Brain," known as YiduCoreThis integration is expected to significantly promote the widespread application and innovative practices of AI technology within the healthcare industryWith the integration of DeepSeek, YiduCore's ability to mine data for value has been greatly improved, allowing it to generate more precise disease insight reportsThis capability effectively bridges the gap between data and real-world applications, offering robust intelligent support for research, diagnosis, and public health scenarios, while simultaneously helping healthcare services reduce costs and increase operational efficiency.
Furthermore, Zhiyun Health's integration of the DeepSeek-R1 model into its AI healthcare system, the Zhiyun Brain, represents another leap forward in the enhancement of data mining capabilities and the efficiency of digital chronic disease management, fostering the emergence of a new form of productivity powered by AI.
Industry experts believe that models like DeepSeek will drive technological iterations, performance enhancements, and cost reductions, ultimately facilitating a transformation within the AI healthcare landscape
Advertisements
These innovations address key challenges that have previously hindered progress, particularly those related to small sample learning, high costs, and accuracy issues.
The future of AI in healthcare appears exceedingly brightRecent figures from Frost & Sullivan indicate that China's AI healthcare market is on track for remarkable growthThe market is projected to escalate from 8.8 billion yuan in 2023 to a staggering 315.7 billion yuan by 2033, with a compound annual growth rate (CAGR) of 43.1% during the period.
In recent years, the Chinese government has implemented a series of policies aimed at fostering sustainable development within the AI healthcare sectorFor example, in November 2024, a joint guideline published by the National Health Commission and other departments, titled "Reference Guide to AI Application Scenarios in Health and Welfare," identified 84 subfields, including AI-assisted medical imaging diagnosticsThis blueprint illustrates the government's commitment to integrating AI technology within healthcare services, community health efforts, and medical education.
Moreover, the exploration of AI, cloud computing, and big data technologies is set to revolutionize the research and development (R&D) processes within the biomedical fieldBy harnessing these technologies, the efficiency of discovering new drug targets and pharmaceuticals will be greatly enhancedSteps are currently being taken to shorten R&D cycles and reduce associated costs through improved data analysis, clinical trials, and pharmacological studies.
In terms of insurance, the National Healthcare Security Administration recently compiled a draft guideline focusing on pricing for medical services related to radiological examinations, for the first time incorporating modern technologies such as AI-assisted diagnosis and cloud storageThis regulatory shift marks a significant milestone, standardizing the deployment of intelligent diagnostic tools within radiology.
On a regional level, various local governments in China are actively responding to these national directives by rolling out their own policies that encourage the deep integration of AI within medical innovations
Advertisements
For example, the city of Shanghai aims to position itself as a global hub for medical AI technology innovation and application.
Investment institutions share the sentiment that AI represents a significant trend within healthcare developmentHaidong International emphasizes that the release of various favorable policies supports the growth of AI in medical applications, thus opening vast potential for future advancements in the sector.
Amidst this rapidly evolving landscape, investment opportunities are becoming increasingly apparentYongxing Securities highlights that the application of AI technologies could potentially reshape traditional healthcare models and create new pathways for growthPharmaceutical companies are recognizing this potential and actively enhancing their strategies in the AI healthcare domain.
For instance, Union Medical has announced plans to invest in Shanghai Union Intelligent Medical Technology Co., acquiring a 0.2849% stake in the company, while Tencent has joined forces with Mindray Medical to unveil the world's first critical care AI modelThis groundbreaking tool can rapidly assess patient vital signs and summarize health conditions in just five seconds.
CITIC Securities expresses that the value of AI in healthcare remains substantial across various sectors, asserting that companies must leverage these advancements to maintain competitive advantagesThis rapidly evolving environment not only benefits established companies but also offers opportunities for newer entrants to thrive through innovationFor domestic enterprises eyeing global markets, developing AI technologies through methods such as acquisition, strategic partnerships, and creating digital ecosystems is becoming increasingly vital.
As AI technology continues to progress, the breadth of application scenarios in AI healthcare will expandDriven by sophisticated models like DeepSeek, healthcare enterprises are transitioning from singular modalities toward multimodal approaches, with a growing trend of specializing in niche areas while evolving into comprehensive AI diagnostic service providers.
Advertisements
Advertisements
Advertisements